Robitussin AC Dosing
For adults and children 12 years and older, the recommended dose is 2 teaspoons (10 mL) every 4 hours, not exceeding 6 doses in 24 hours; for children 6 to under 12 years, give 1 teaspoon (5 mL) every 4 hours with the same maximum frequency; children under 6 years require physician consultation before use. 1
Age-Specific Dosing Guidelines
Adults and Adolescents (≥12 years)
- Dose: 2 teaspoons (10 mL) every 4 hours 1
- Maximum: 6 doses per 24-hour period 1
- Active ingredients per dose: Guaifenesin 200 mg + Codeine phosphate 10 mg (typical Robitussin AC formulation)
Children 6 to Under 12 Years
- Dose: 1 teaspoon (5 mL) every 4 hours 1
- Maximum: 6 doses per 24-hour period 1
- Important: Use a proper measuring device to ensure accurate dosing 1
Children Under 6 Years
- Recommendation: Consult a physician before use 1
- Rationale: Safety and efficacy have not been adequately established in this age group, and the risk of serious side effects increases with inappropriate dosing 1
Critical Safety Considerations
When to Avoid Use
- Do not use if the patient has persistent cough from smoking, asthma, chronic bronchitis, or emphysema 1
- Do not use if cough is accompanied by excessive phlegm production 1
- Avoid in patients with chronic pulmonary disease or shortness of breath 1
Monitoring and Follow-Up
- Discontinue use if symptoms persist beyond 7 days, recur, or are accompanied by fever, rash, or persistent headache 1
- These warning signs may indicate a serious underlying condition requiring medical evaluation 1
Special Populations
- Pregnancy and breastfeeding: Consult healthcare provider before use 1
- Constipation risk: Codeine may cause or worsen constipation 1
- Drug interactions: Exercise caution when combining with other medications, particularly in children 1
Evidence Context for Cough Suppressants
While the FDA-approved dosing for Robitussin AC is clear, it's worth noting that evidence for antitussive efficacy in acute bronchitis shows mixed results. Codeine-based preparations demonstrate modest cough reduction (40-60% reduction in cough counts at doses of 30-60 mg in adults), though clinical significance varies 2. The ACCP guidelines suggest antitussive agents are occasionally useful for short-term symptomatic relief in acute bronchitis, though the benefit is considered small/weak (Grade C recommendation) 2.
Common Pitfalls to Avoid
- Age-based vs. weight-based dosing errors: Parents frequently make dosing errors with age-based schedules; emphasize using the exact measuring device provided 1
- Exceeding maximum daily doses: Clearly communicate the 6-dose maximum per 24 hours to prevent overdose 1
- Inappropriate use for chronic conditions: This medication is for acute cough only, not for chronic respiratory conditions 1
- Combining with other cough/cold products: Risk of duplicate active ingredients and overdose 1